Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy and other neurological disorders. Our core technology has been developed at Mayo Clinic and is under clinical evaluation. Founded in 2017 and headquartered in Redmond, Washington, Cadence is led by seasoned executives with an extensive background in neural implant product development and first-in-human clinical studies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/06/19 | $15,000,000 | Series A |
Epilepsy Foundation of America Jazz Venture Partners  Mayo Benefactors Innovation Fund Mayo Clinic Ventures | undisclosed |
